Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0885-3924(02)00479-7 | DOI Listing |
Int J Pharm
May 2024
Department of Chemical Engineering (BK21 FOUR Integrated Engineering Program), Kyung Hee University, Yongin 17104, South Korea. Electronic address:
Crit Care Explor
February 2024
Kingston Health Sciences Centre, Kingston, ON, Canada.
Objectives: Respiratory failure secondary to COVID-19 is associated with morbidity and mortality. Current anti-inflammatory therapies are effective but are given systemically and have significant side effects. Furosemide has anti-inflammatory properties, can be administered by inhalation, and is inexpensive.
View Article and Find Full Text PDFBMJ Open
November 2023
Department of Critical Care Medicine, Queen's University, Kingston, Ontario, Canada
Introduction: Obstructive lung diseases (OLDs) such as asthma and chronic obstructive pulmonary disease are major global sources of morbidity and mortality. Current treatments broadly include bronchodilators such as beta agonists/antimuscarinics and anti-inflammatory agents such as steroids. Despite therapy patients still experience exacerbations of their diseases and overall decline over time.
View Article and Find Full Text PDFBJR Case Rep
September 2021
Department of Neuroradiology, Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom.
We present a 1-year-old boy who presented to the emergency department with a 7-day history of diarrhoea and vomiting. The initial renal function profile demonstrated a urea of 55 mmol l (normal range between 5 and 20 mmol l), creatinine 695 micromol/L (normal range between 62-106 micromol/L) and potassium 9.1 mmol l (normal range between 3.
View Article and Find Full Text PDFTanaffos
December 2020
Clinical Research Development Unit, Shahid Mostafa Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.
Background: Chronic obstructive pulmonary disease (COPD) is one of the most common chronic illnesses in humans. Among both oral and intravenous diuretics, nebulizing furosemide (Lasix) is the most commonly used agent. The purpose of this study was to ascertain the therapeutic effects of nebulizing furosemide compared with placebo in the treatment of COPD using a systematic review and meta-analysis of clinical trials.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!